HOME >> MEDICINE >> NEWS
Heart Attack Survivors Can Lower Stroke Risk By Taking Cholesterol-Lowering Drug, Study Says

mined whether lowering cholesterol in people who survived a first heart attack reduced the risk of a second attack. Both studies did find a reduced heart attack risk and evidence that lowering cholesterol also lowered a survivor's stroke risk.

Each study used a different drug from a group called HMG-CoA reductase inhibitors: simvastatin (Zocor) in the Scandinavian Simvastatin Survival Study (4S) and pravastatin in CARE. Researchers who designed 4S did not plan to test simvastatin's effectiveness in stroke, but in 1994 they reported a retrospective analysis that showed fewer strokes in patients getting simvastatin.

CARE, however, did include stroke reduction as a secondary part of its investigation. Plehn says that this part of the investigation makes the CARE stroke analysis more acceptable to statisticians. The team's initial paper in 1996 reported a 31 percent reduction in stroke, based on the reports of study investigators.

The new stroke analysis presented at the American Heart Association meeting involved a far-more detailed examination of the CARE data. The records of any patient who might have suffered a stroke were examined by two members of a special committee.

"Strokes are sometimes hard to diagnose," Plehn says. "We looked at hundreds of reported events to verify that they had indeed been strokes and not migraine headaches or something else that might appear to be strokes."

This work revealed that 128 CARE participants (52 taking pravastatin and 76 on placebo) suffered confirmed strokes during the median follow-up period of five years. The data showed a 32 percent lower risk for the drug group. A total of 216 people (92 on pravastatin and 124 on placebo) suffered either a stroke or TIA, a risk reduction of 27 percent for those getting pravastatin.

These findings held up when the team adjusted the results for age, sex, history of hypertension, cigarette smoking, diabetes, and levels of t
'"/>

Contact: Brian Henry
brianh@amhrt.org
214-706-1135
American Heart Association
7-Feb-1998


Page: 1 2 3

Related medicine news :

1. The European Society of Cardiology launches Women at Heart
2. Heart surgeons publish death rates
3. Heart attack treatment gap may be closing for women
4. The Larry King Cardiac Foundation presents The Changing Face of Heart Disease on Feb. 2
5. Brenner Childrens Hospital named to NIH Pediatric Heart Network
6. Heart patients treated by non-cardiologists less likely to receive medications
7. Heart failure patients treated for diabetes with insulin have increase in mortality
8. New research results: Heart jacket shown to be effective
9. Heart surgery patients receive less aggressive discharge care
10. Heart attack, stroke risk overlooked in diabetics
11. Heart arrhythmias easily treated, yet few know risks

Post Your Comments:
(Date:10/31/2014)... In an effort to expand services and improve efficiency ... will soon offer orthodontics at his Oral & Maxillofacial Surgery ... , To build upon the high degree of care and ... known for, Dr. Jamali is welcoming an orthodontist that is ... as UCLA, Stanford and UCSF. He added that the new ...
(Date:10/31/2014)... 2014 Phoenix dentist , Dr. Christy, ... November. Whether patients simply need routine care or have a ... than now to get that necessary care. The right dental ... routine and even essential treatments due to financial concerns. Throughout ... on any treatments offered by the team at Christy Dental ...
(Date:10/31/2014)... Uniwigs.com newly arrived flip in hair extensions are ... itself around people’s heads with a transparent miracle wire undetectable ... comes with adjustable loops, which are improved over the basic ... now adjust the wire to best fit the size of ... generation of flip ins, they simply need to adjust the ...
(Date:10/31/2014)... 31, 2014 Med-Care Diabetic & Medical ... highest principles of patient care and service, announced a ... and wellness website, to provide an online Diabetes ... , The Diabetes Health Center will provide topical information ... living with diabetes. Content will feature advice from leading ...
(Date:10/31/2014)... FRIDAY, Oct. 31, 2014 (HealthDay News) -- A few simple ... cope with, a sleep expert says. "Adjusting to the ... bit easier than handling the time change in the spring. ... sleep for the fall time change," Dr. Praveen Rudraraju, director ... in Mount Kisco, N.Y., said in a hospital news release. ...
Breaking Medicine News(10 mins):Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 2Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 3Health News:Phoenix Dentist, Dr. Christy, is Now Offering Ten Percent Off On All Dental Treatments for the Month of November 2Health News:UniWigs Unveiles New Generation of Flip In Hair Extensions 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 3Health News:Make the Most of This Weekend's Time Change 2
(Date:10/31/2014)... 31, 2014 Oramed Pharmaceuticals ... company focused on the development of oral drug ... a conference call to discuss the clinical results ... the company,s proprietary oral insulin capsules, to treat ... at 10:00 a.m. Eastern time. Shareholders ...
(Date:10/31/2014)... 31, 2014 Investor-Edge has initiated ... NSPH ), Isis Pharmaceuticals Inc. (NASDAQ: ... ), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ), ... these five companies can be accessed at: http://investor-edge.com/register ... NASDAQ Composite ended at 4,566.14, up 0.37%, the Dow ...
(Date:10/31/2014)... 3, 2014 British Journal ... BPH to discuss "male orgasmic dysfunction" with their doctor ... treat prostate symptoms while preserving sexual function   ... publication of a paper in the British Journal of ... prostate to discuss with their doctors the likely impact ...
Breaking Medicine Technology:Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5Sexual Dysfunction No Longer Inevitable When Treating Enlarged Prostate 2
Cached News: